Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache.
Jean Schoenen, Agneta Henriette Snoer, Roemer B Brandt...
https://pubmed.ncbi.nlm.nih.gov/36268950/Actively Recruiting
Led by Beijing Tiantan Hospital · Updated on 2025-01-27
108
Participants Needed
1
Research Sites
52 weeks
Total Duration
Cluster headache is a severe condition marked by intense one-sided headaches and related nerve symptoms, affecting about 0.1% of people each year. This trial aims to evaluate the safety and effectiveness of using pulsed radiofrequency PRF treatment targeting the sphenopalatine ganglion SPG for patients suffering from chronic cluster headache. The study is randomized and controlled to provide clear evidence about this treatment approach. Participants will receive one of two treatments after a needle reaches the SPG. The experimental group will get PRF treatment for 360 seconds at a set temperature and pulse frequency. The comparison group will receive a nerve block using a mixture of medications including triamcinolone and bupivacaine. The study will monitor participants for up to one year to assess the effects of these procedures. During the study, researchers will track the frequency and intensity of headache attacks using regular assessments over 12 months. They will also collect patient feedback on improvement and satisfaction. Safety will be monitored by recording any adverse events within a year after treatment. Participation involves regular follow-up visits to evaluate outcomes and ensure ongoing safety and care.
CONDITIONS
SPG Pulsed Radiofrequency for Chronic Cluster Headache
F
Fang Luo
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beijing Tiantan Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive pulsed radiofrequency treatment or nerve block at the sphenopalatine ganglion.
1 procedure visit (in-person)
Duration - 12 months
Participants are monitored for efficacy and safety outcomes over 1 year after the procedure.
Visits at month 1, month 2, month 3, month 6, and month 12 after procedure
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jean Schoenen, Agneta Henriette Snoer, Roemer B Brandt...
https://pubmed.ncbi.nlm.nih.gov/36268950/Leopoldine A Wilbrink, Ilse F de Coo, Patty G G Doesborg...
https://pubmed.ncbi.nlm.nih.gov/34146510/Peter J Goadsby, Soma Sahai-Srivastava, Eric J Kezirian...
https://pubmed.ncbi.nlm.nih.gov/31701891/Beijing Tiantan Hospital
Lead Sponsor